25G微创玻璃体切除术治疗玻璃体积血的临床观察
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Clinical study of 25G micro-incision vitrectomy on vitreous hemorrhage
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨25G微创玻璃体切除术治疗玻璃体积血的临床疗效和安全性。

    方法:回顾性分析2012-01/2014-06经过视力、眼压、裂隙灯、眼底及B超等检查诊断为玻璃体积血患者200例208眼,所有患者采用25G微创玻璃体切除术。比较术前、术后1wk,1、3、6mo最佳矫正视力。观察眼压、前房炎症反应、眼底情况等临床资料。

    结果:术前视力光感16眼,手动82眼,指数49眼,0.01~0.09者38眼,0.1~0.2者23眼; 术后6mo视力手动1眼,指数2眼,0.01~0.09者31眼,0.1~0.2者29眼,0.2以上者145眼,术后所有患者视力稳定或不同程度提高,手术前后视力差异具有统计学意义(Z=-4.128,P=0.000)。术前平均眼压15.29±3.62mmHg,术后6mo平均眼压13.67±4.93mmHg。其中糖尿病性视网膜病变96眼(46.2%),视网膜分支静脉阻塞37眼(17.8%),视网膜中央静脉阻塞9眼(4.3%),视网膜静脉周围炎13眼(6.25%),息肉样脉络膜视网膜病13眼(6.25%),视网膜大动脉瘤5眼(2.4%),视网膜裂孔19眼(9.1%),Terson综合征16眼(7.7%)。术中联合白内障手术23眼(11.1%),术中玻璃体腔填充灌注液145眼(69.7%),C3F8气体21眼(10.1%),空气17眼(8.2%),硅油25眼(12.0%)。术后并发症:12眼(5.8%)出现术后早期一过性低眼压,8眼(3.8%)术后早期高眼压,19眼(9.1%)出现前房炎症反应,10眼(4.8%)术后早期玻璃体再出血,余所有患者在治疗过程中及治疗后随访均未见眼部或全身不良反应。

    结论:采用25G微创玻璃体切除术治疗玻璃体积血是安全有效的,具有创伤小、时间短、恢复快。

    Abstract:

    AIM:To investigate the safety and effectiveness of 25G micro-incision vitrectomy on vitreous hemorrhage.

    METHODS:A retrospective review of 200 patients(208 eyes)who were diagnosed as vitreous hemorrhage through the best-corrected visual acuity(BCVA),intraocular pressure(IOP),examination of slit lamp, examination of the ocular fundus and B-mode ultrasongography from January 2012 to June 2014 was taken. All patients were treated by 25G micro-incision vitrectomy. At 1wk,1,3 and 6 mo after the surgeries, the BCVA was retrospectively observed. The changes of IOP, inflammatory reaction and the ocular fundus were observed.

    RESULTS: The BCVA was light perception in 16 eyes, hand moving in 82 eyes,finger counting in 49 eyes, 0.01~0.09 in 38 eyes,0.1~0.2 in 23 eyes pre-operatively. At 6mo after operations,the BCVA were hand moving in 1 eyes, finger counting in 2 eyes,0.01~0.09 in 31 eyes, 0.1~0.2 in 29 eyes,>0.2 in 145 eyes. The BCVA of all patients kept stable or increased after operations and the difference before and after the operation was statistically significant(Z=-4.128, P=0.000). The pre-operative mean IOP was 15.29±3.62mmHg. The mean IOP was 13.67±4.93mmHg at 6mo after operations. There were 96 eyes(46.2%)due to diabetic retinopathy,37 eyes(17.8%)due to branch retinal vein obstruction,9 eyes(4.3%)due to central retinal vein obstruction,13 eyes(6.25%)due to retinal periphlebitis,13 eyes(6.25%)due to polypoidal choroidal vasculopathy(PCV),5 eyes(2.4%)due to large retinal aneurys,19 eyes(9.1%)due to retinal hole,16 eyes(7.7%)due to Terson syndrome. Phacoemulcification was performed for 23 eyes(11.1%)during operations. There were 145 eyes(69.7%)with perfusion fluid,21 eyes(10.1%)with C3F8 gas tamponade,17 eyes(8.2%)with air tamponade,25 eyes(12.0%)with silicone oil tamponade. There were 12 eyes(5.8%)with transient hypotony, 8 eyes(3.8%)with increased IOP, 19 eyes(9.1%)with inflammation in anterior chamber, and 10 eyes(4.8%)with vitreous hemorrhage after the surgery. There were no ocular or systemic adverse events observed in other patients.

    CONCLUSION: The 25G micro-incision vitrectomy is an effective and safe treatment for the patients with vitreous hemorrhage because of small injury, short operation time, quick recovery.

    参考文献
    相似文献
    引证文献
引用本文

黄志坚,陈晓,洪玲,等.25G微创玻璃体切除术治疗玻璃体积血的临床观察.国际眼科杂志, 2016,16(1):118-120.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2015-07-15
  • 最后修改日期:2015-12-17
  • 录用日期:
  • 在线发布日期: 2015-12-28
  • 出版日期: